At a glance
- Originator Nonindustrial source
- Class Alkaloids; Antidementias; Neuroprotectants; Small molecules
- Mechanism of Action Muscarinic M2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 24 Jul 1996 New profile
- 24 Jul 1996 Discontinued-Preclinical for Cognition disorders in USA (Unknown route)